Favorable Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Acute Promyelocytic Leukemia in Childhood

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1704676
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

CAR-T Cells and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Immunotherapy
OncologyAllergyImmunology
2017English

Clofarabine, Cytarabine, and Mitoxantrone in Refractory/Relapsed Acute Myeloid Leukemia: High Response Rates and Effective Bridge to Allogeneic Hematopoietic Stem Cell Transplantation

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2020English

Pcn126 - Direct Cost Study of Allogeneic Hematopoietic Stem Cell Transplantation (Ahsct) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients From the French Hospital Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Extramedullary Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Therapy With Imatinib Mesylate (Glivec) Preceding Allogeneic Stem Cell Transplantation (SCT) in Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

Allogeneic Hemopoietic Stem Cell Transplants for Patients With Relapsed Acute Leukemia: Long-Term Outcome

Bone Marrow Transplantation
TransplantationHematology
2007English

Haploidentical Hematopoietic Stem Cell Transplantation Compared With Hla-Matched Stem Cell Transplantation for Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy